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Trends in baseline characteristics and outcomes of Medicare beneﬁciaries who underwent PCI from
1/2000-11/2012
Overall 2000 2002 2004 2006 2008 2010 2012
number 3387976 246528 293391 332988 318622 243418 204409 161667
median age(years) 75 75 75 75 75 75 75 75
female (%) 42.1 43.5 43.1 42.5 41.8 41.5 41 40.4
white (%) 90 91.5 90.9 90.4 89.9 89.5 88.6 88.1
HTN (%) 65.6 58.4 61.7 63.5 62.2 65.2 74.3 80.1
DM (%) 29.9 26 27.3 28.2 28.1 29 35.5 40.2
PVD (%) 4.9 4.3 4.7 4.5 4.7 4.7 5.2 6.6
Stroke/TIA (%) 4.2 4.4 4.2 3.9 3.7 4 4.7 5.6
HF (%) 23.4 22.3 22.3 22.4 22.6 21.3 26.2 29.9
renal failure (%) 10 3.6 4.5 5.4 12.2 10.5 17.6 24.5
acute MI (%) 29.9 26.9 27.5 26.1 25.9 30.8 37.6 45.8
elective (%) 43.1 39.1 41.5 45.3 47.4 40.1 40.2 47
post-procedure LOS
(days)
2 2 2 2 2 2 2 3
hospital mortality (%) 2.1 2.1 2 1.8 1.8 2.1 2.4 3.1
30 day mortality (%) 3.1 3 2.8 2.6 2.7 3.2 3.7 4.6
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terized by higher comorbidity burden and higher incidence of acute
MI. Hospital mortality increased signiﬁcantly over time, especially
for patients presenting electively. Following adjustment for wors-
ening baseline characteristics over time, adjusted hospital mortality
was 42% higher in 2012 compared to 2000, OR 1.42 (95% CI 1.36–
1.48).
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BACKGROUND We aimed to evaluate the angiographic and long-term
clinical outcomes after treatment for left main coronary artery disease
(LMCAD) with bare-metal stents (BMS), ﬁrst-generation, and second-
generation drug-eluting stents (G1-DES and G2-DES).
METHODS The Left Main Coronary Stenting Registry in Japan is a
multicenter registry enrolling 1800 consecutive patients with
LMCAD treated with stent implantation between 2004 and 2012: 355
patients with BMS, 875 with G1-DES, and 570 with G2-DES. The
clinical endpoints assessed included all-cause death, cardiac death,
sudden death, deﬁnite or probable stent thrombosis, and target-
lesion revascularization (TLR). We distinguished in-hospital death
from long-term clinical outcomes. The 6-year cumulative rates of
adverse events were estimated by Kaplan-Meier methods with p
values from log-rank tests. The angiographic endpoint was deﬁned
as in-stent restenosis within one year after procedure. In addition
to restenosis at stent-implanted site, restenosis at bifurcation
site was deﬁned as a percent diameter >50% within 5 mm from
the stent-implanted bifurcation lesion in both main and side
branches.
RESULTS The median follow-up duration was 3.9 years (the ﬁrst
and third quarters, 2.2 and 5.9 years). Among patients with BMS,
G1-DES, and G2-DES, there were no signiﬁcant differences in the
cumulative 6-year incidences of all-cause death (24.8% vs. 23.0%
vs. 23.8%, p¼0.48), cardiac death (8.3% vs. 10.2% vs. 5.4%,
p¼0.65), sudden death (2.4% vs. 3.7% vs. 2.0%, p¼0.95), and deﬁ-
nite or probable stent thrombosis (1.6% vs. 0.8% vs. 2.1%, p¼0.11),whereas patients with BMS had a signiﬁcantly higher cumulative
rate of TLR than those with G1- and G2-DES (26.6% vs. 15.4% vs.
10.4%, p<0.001). In this study sample, 1394 patients (77.4%) un-
derwent follow-up angiography within one year after the initial
procedure. The in-stent restenosis rate was signiﬁcantly higher in
patients with BMS than in those with 1st and 2nd DES (27.2% vs.
11.7% vs. 5.7%, p<0.001). The restenosis rate in the proximal left
main stem showed no signiﬁcant difference between patients with
G1- and G2-DES (3.2% vs. 2.4%, p¼0.48), whereas the main and side
bifurcation restenosis rates were signiﬁcantly higher in patients
with G1-DES than in those with G2-DES (5.0% vs. 2.4%, p¼0.04 and
5.3% vs. 1.3%, p<0.001).
CONCLUSIONS DES for LMCAD appeared to be associated with more
favorable outcomes of TLR than BMS. Although G2-DES improved the
in-stent restenosis rate compared with G1-DES, especially in both
main and side bifurcation lesions, long-term clinical outcomes after
stent implantation for LMCAD were comparable between G1- and G2-
DES.
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BACKGROUND Peripheral vascular interventions with drug eluting
balloons (DEB) have been demonstrated to be superior to balloon
angioplasty (BA) in short-term follow up (6 months). Long-term out-
comes remain uncertain and we therefore assessed the long-term
outcomes at or beyond 12 months in this meta-analysis.
METHODS PubMed, EBSCO and Ovid databases were searched to
identify randomized controlled trials (RCT) comparing drug-eluting
balloons with balloon angioplasty for the management of femo-
ropopliteal and or infrapopliteal vascular disease. Outcomes of
target lesion revascularization (TVR), patency rates, death and
amputations were compared between the two groups using random
effects models and risk ratio (RR) with 95% conﬁdence intervals
were calculated.
RESULTS A total of 9 RCT’s were identiﬁed and included 1058
patients. Of these, 585 and 473 patients were randomized to DEB
and BA groups, respectively. The risk of TLR was signiﬁcantly lower
in the DEB group at 12 months (RR 0.34, 95% CI 0.22 – 0.53,
p<0.01) and 24 months (RR 0.37, 95% CI 0.16 – 0.84, p¼0.02)
compared to BA group. The patency rates were higher with the use
of DEB (RR 1.64, 95% CI 1.44 – 1.86, p<0.01). The risk of death was
similar in both the groups (RR 1.23, 95% CI 0.65 – 2.34, p¼0.52).
There was a favorable trend towards decrease in amputations with
the use of DEB, however this ﬁnding was not statistically signiﬁcant
(RR 0.64, 95% CI 0.17 – 2.53, p¼0.54). Heterogeneity was very low
among the included studies as assessed by Cochrane Q statistic
(I2¼25%). Publication bias was assessed by means of funnel plot
and this was deemed to be minimal.
